Enovis Corporation (LON:0I1B)

Market Cap	1.11B -25.1%
Revenue (ttm)	1.73B +6.0%
Net Income	-861.61M
EPS	-15.06
Shares Out	n/a
PE Ratio	n/a
Forward PE	6.79
Dividend	n/a
Ex-Dividend Date	n/a

Volume	205
Average Volume	192
Open	25.48
Previous Close	25.98
Day's Range	25.48 - 25.89
52-Week Range	21.30 - 36.56
Beta	1.52
RSI	56.95
Earnings Date	May 7, 2026

About Enovis

Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The Prevention and Recovery segment offers rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, electrical stimulators for pain management, and physical therapy products which are used by orthopedic specialists, surgeons, primary ca...

• Industry: Industrial - Capital Goods
• Sector: Industrials
• Founded: 1995
• Employees: 7,802
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0I1B

Financial Performance

In 2025, Enovis's revenue was $2.25 billion, an increase of 6.66% compared to the previous year's $2.11 billion. Losses were -$1.18 billion, 43.5% more than in 2024.

Financial numbers in USD